drugset / Trial / NCT00002448

A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients

NCT00002448

Phase 3 Completed 40 enrolled Hoffmann-La Roche
Parallel-groupTreatment

Summary

The purpose of this study is to examine how the immune systems of HIV-infected patients react to 2 anti-HIV drug combinations.

Timeline

Start
1999-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Efavirenz Other / unclassified
Subject Ritonavir Other / unclassified
Subject Saquinavir Small molecule